Heart disease

FILE - In this Jan. 2, 2020, file photo, a commuter wears a mask as smoke shrouds the Australian capital of Canberra, Australia. It's an unprecedented dilemma for Australians accustomed to blue skies and sunny days that has raised fears for the long-term health consequences if prolonged exposure to choking smoke becomes the new summer norm. (AP Photo/Mark Baker, File)
January 15, 2020 - 1:00 am
CANBERRA, Australia (AP) — Fire alarms have been sounding in high-rise buildings across downtown Sydney and Melbourne as dense smoke from distant wildfires confuse electronic sensors. Modern government office blocks in the Australian capital Canberra have been closed because the air inside is too...
Read More
FILE - In this Jan. 2, 2020, file photo, a commuter wears a mask as smoke shrouds the Australian capital of Canberra, Australia. It's an unprecedented dilemma for Australians accustomed to blue skies and sunny days that has raised fears for the long-term health consequences if prolonged exposure to choking smoke becomes the new summer norm. (AP Photo/Mark Baker, File)
January 14, 2020 - 10:54 pm
CANBERRA, Australia (AP) — Fire alarms have been sounding in high-rise buildings across downtown Sydney and Melbourne as dense smoke from distant wildfires confuse electronic sensors. Modern government office blocks in the Australian capital Canberra have been closed because the air inside is too...
Read More
This undated photo provided by Amarin in November 2018 shows a capsule of the purified, prescription fish oil Vascepa. On Friday, Dec. 13, 2019, U.S. regulators approved expanded use of the medication for preventing serious heart complications in high-risk patients already taking cholesterol-lowering pills. (Amarin via AP)
December 13, 2019 - 5:56 pm
TRENTON, N.J. (AP) — U.S. regulators on Friday approved expanded use of a fish oil-based drug for preventing serious heart complications in high-risk patients already taking cholesterol-lowering pills. Vascepa was approved years ago for people with sky-high triglycerides, a type of fat in blood...
Read More
This undated photo provided by Amarin in November 2018 shows a capsule of the purified, prescription fish oil Vascepa. On Friday, Dec. 13, 2019, U.S. regulators approved expanded use of the medication for preventing serious heart complications in high-risk patients already taking cholesterol-lowering pills. (Amarin via AP)
December 13, 2019 - 5:53 pm
TRENTON, N.J. (AP) — U.S. regulators on Friday approved expanded use of a fish oil-based drug for preventing serious heart complications in high-risk patients already taking cholesterol-lowering pills. Vascepa was approved years ago for people with sky-high triglycerides, a type of fat in blood...
Read More
December 13, 2019 - 5:35 pm
TRENTON, N.J. (AP) — U.S. regulators on Friday approved expanded use of a fish oil-based drug for preventing serious heart complications in high-risk patients already taking cholesterol-lowering pills. Vascepa was approved years ago for people with sky-high triglycerides, a type of fat in blood...
Read More
FILE - This May 26, 2009 file photo shows a printout from an electrocardiogram machine in Missouri. Doctors are reporting that novel drugs may offer fresh ways to reduce heart risks beyond the usual medicines to lower cholesterol and blood pressure. One new study found that heart attack survivors benefited from a medicine long used to treat gout. Gene-targeting medicines also showed promise in studies discussed Monday, Nov. 18, 2019, at an American Heart Association conference in Philadelphia. (AP Photo/Jeff Roberson)
November 18, 2019 - 3:26 pm
PHILADELPHIA (AP) — Novel drugs may offer fresh ways to reduce heart risks beyond the usual medicines to lower cholesterol and blood pressure. One new study found that heart attack survivors benefited from a medicine long used to treat gout. Several experimental drugs also showed early promise for...
Read More
FILE - This May 26, 2009 file photo shows a printout from an electrocardiogram machine in Missouri. Doctors are reporting that novel drugs may offer fresh ways to reduce heart risks beyond the usual medicines to lower cholesterol and blood pressure. One new study found that heart attack survivors benefited from a medicine long used to treat gout. Gene-targeting medicines also showed promise in studies discussed Monday, Nov. 18, 2019, at an American Heart Association conference in Philadelphia. (AP Photo/Jeff Roberson)
November 18, 2019 - 2:12 pm
PHILADELPHIA (AP) — Novel drugs may offer fresh ways to reduce heart risks beyond the usual medicines to lower cholesterol and blood pressure. One new study found that heart attack survivors benefited from a medicine long used to treat gout. Several experimental drugs also showed early promise for...
Read More
November 18, 2019 - 1:49 pm
PHILADELPHIA (AP) — Doctors are reporting that novel drugs may offer fresh ways to reduce heart risks beyond the usual medicines to lower cholesterol and blood pressure. One new study found that heart attack survivors benefited from a medicine long used to treat gout. The drug, colchicine, works by...
Read More
In this Feb. 16, 2017 file photo, surgeons perform a non-emergency angioplasty at Mount Sinai Hospital in New York. Through a blood vessel in the groin, a tube is guided to a blockage in the heart. A tiny balloon is then inflated to flatten the clog, and a mesh tube called a stent is inserted to prop the artery open. According to a federally funded study released on Saturday, Nov. 16, 2019, people with severe but stable heart disease from clogged arteries may have less chest pain if they get a procedure to improve blood flow rather than just giving medicines a chance to help, but it won't cut their risk of having a heart attack or dying over the following few years. (AP Photo/Mark Lennihan)
November 16, 2019 - 2:02 pm
PHILADELPHIA (AP) — People with severe but stable heart disease from clogged arteries may have less chest pain if they get a procedure to improve blood flow rather than just giving medicines a chance to help, but it won't cut their risk of having a heart attack or dying over the following few years...
Read More
In this Feb. 16, 2017 file photo, surgeons perform a non-emergency angioplasty at Mount Sinai Hospital in New York. Through a blood vessel in the groin, a tube is guided to a blockage in the heart. A tiny balloon is then inflated to flatten the clog, and a mesh tube called a stent is inserted to prop the artery open. According to a federally funded study released on Saturday, Nov. 16, 2019, people with severe but stable heart disease from clogged arteries may have less chest pain if they get a procedure to improve blood flow rather than just giving medicines a chance to help, but it won't cut their risk of having a heart attack or dying over the following few years. (AP Photo/Mark Lennihan)
November 16, 2019 - 2:01 pm
PHILADELPHIA (AP) — A large study finds that people with severe but stable heart disease from clogged arteries may have less chest pain if they get a procedure to improve blood flow rather than just giving medicines a chance to help, but it won't cut their risk of having a heart attack or dying...
Read More

Pages